• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别胶质瘤的放射基因组学:一种作为生存预测生物学替代指标的放射组学特征

Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.

作者信息

Qian Zenghui, Li Yiming, Sun Zhiyan, Fan Xing, Xu Kaibin, Wang Kai, Li Shaowu, Zhang Zhong, Jiang Tao, Liu Xing, Wang Yinyan

机构信息

Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

Aging (Albany NY). 2018 Oct 22;10(10):2884-2899. doi: 10.18632/aging.101594.

DOI:10.18632/aging.101594
PMID:30362964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6224242/
Abstract

OBJECTIVE

We aimed to identify a radiomic signature to be used as a noninvasive biomarker of prognosis in patients with lower-grade gliomas (LGGs) and to reveal underlying biological processes through comprehensive radiogenomic investigation.

METHODS

We extracted 55 radiomic features from T2-weighted images of 233 patients with LGGs (training cohort: = 85; validation cohort: = 148). Univariate Cox regression and linear risk score formula were applied to generate a radiomic-based signature. Gene ontology analysis of highly expressed genes in the high-risk score group was conducted to establish a radiogenomic map. A nomogram was constructed for individualized survival prediction.

RESULTS

The six-feature radiomic signature stratified patients in the training cohort into low- or high-risk groups for overall survival ( = 0.0018). This result was successfully verified in the validation cohort ( = 0.0396). Radiogenomic analysis revealed that the prognostic radiomic signature was associated with hypoxia, angiogenesis, apoptosis, and cell proliferation. The nomogram resulted in high prognostic accuracy (C-index: 0.92, C-index: 0.70) and favorable calibration for individualized survival prediction in the training and validation cohorts.

CONCLUSIONS

Our results suggest a great potential for the use of radiomic signature as a biological surrogate in providing prognostic information for patients with LGGs.

摘要

目的

我们旨在识别一种放射组学特征,用作低级别胶质瘤(LGG)患者预后的非侵入性生物标志物,并通过全面的放射基因组学研究揭示潜在的生物学过程。

方法

我们从233例LGG患者的T2加权图像中提取了55个放射组学特征(训练队列:n = 85;验证队列:n = 148)。应用单变量Cox回归和线性风险评分公式生成基于放射组学的特征。对高风险评分组中高表达基因进行基因本体分析,以建立放射基因组图谱。构建列线图用于个体生存预测。

结果

在训练队列中,六特征放射组学特征将患者分为总生存的低风险或高风险组(P = 0.0018)。这一结果在验证队列中得到成功验证(P = 0.0396)。放射基因组分析显示,预后放射组学特征与缺氧、血管生成、细胞凋亡和细胞增殖相关。列线图在训练和验证队列中对个体生存预测具有较高的预后准确性(C指数:0.92,C指数:0.70)和良好的校准。

结论

我们的结果表明,放射组学特征作为一种生物学替代物,在为LGG患者提供预后信息方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/509249f34feb/aging-10-101594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/984e726b48dc/aging-10-101594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/4a5bdeda18c1/aging-10-101594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/13f1404ffc41/aging-10-101594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/509249f34feb/aging-10-101594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/984e726b48dc/aging-10-101594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/4a5bdeda18c1/aging-10-101594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/13f1404ffc41/aging-10-101594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f273/6224242/509249f34feb/aging-10-101594-g004.jpg

相似文献

1
Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.低级别胶质瘤的放射基因组学:一种作为生存预测生物学替代指标的放射组学特征
Aging (Albany NY). 2018 Oct 22;10(10):2884-2899. doi: 10.18632/aging.101594.
2
Identification and validation of a 21-mRNA prognostic signature in diffuse lower-grade gliomas.鉴别和验证弥漫性低级别神经胶质瘤中 21 个 mRNA 的预后签名。
J Neurooncol. 2020 Jan;146(1):207-217. doi: 10.1007/s11060-019-03372-z. Epub 2019 Dec 18.
3
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.一种基于放射组学特征的无创预测模型,用于预测低级别胶质瘤患者的无进展生存期。
Neuroimage Clin. 2018;20:1070-1077. doi: 10.1016/j.nicl.2018.10.014. Epub 2018 Oct 16.
4
An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.预测低级别胶质瘤预后的免疫相关标志物。
Front Immunol. 2020 Dec 8;11:603341. doi: 10.3389/fimmu.2020.603341. eCollection 2020.
5
Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.基于 MRI 放射组学、遗传和临床风险因素的机器学习技术提高高级别胶质瘤的生存预测。
Eur J Radiol. 2019 Nov;120:108609. doi: 10.1016/j.ejrad.2019.07.010. Epub 2019 Jul 13.
6
Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.常规磁共振成像的放射组学特征可预测 II 级和 III 级脑胶质瘤中端粒酶逆转录酶启动子突变状态。
Neuroradiology. 2020 Jul;62(7):803-813. doi: 10.1007/s00234-020-02392-1. Epub 2020 Apr 1.
7
Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.基于多参数 MRI 的影像组学列线图构建预测胶质瘤患者分级的模型:一项队列研究。
J Magn Reson Imaging. 2019 Mar;49(3):825-833. doi: 10.1002/jmri.26265. Epub 2018 Sep 8.
8
Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.使用 MRI 放射组学特征预测低级别胶质瘤中的 ATRX 突变。
Eur Radiol. 2018 Jul;28(7):2960-2968. doi: 10.1007/s00330-017-5267-0. Epub 2018 Feb 5.
9
Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.基于影像组学特征预测低级别胶质瘤的 Ki-67 表达水平和生存情况。
J Neurooncol. 2017 Nov;135(2):317-324. doi: 10.1007/s11060-017-2576-8. Epub 2017 Sep 12.
10
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.由六个免疫基因组成的风险评分特征可预测低级别胶质瘤患者的总生存期。
Comput Math Methods Med. 2022 Feb 11;2022:2558548. doi: 10.1155/2022/2558548. eCollection 2022.

引用本文的文献

1
Advanced MRI, Radiomics and Radiogenomics in Unravelling Incidental Glioma Grading and Genetic Status: Where Are We?高级磁共振成像、影像组学和放射基因组学在解读偶然发现的胶质瘤分级和基因状态中的应用:我们目前的进展如何?
Medicina (Kaunas). 2025 Aug 12;61(8):1453. doi: 10.3390/medicina61081453.
2
Hybrid classical and quantum computing for enhanced glioma tumor classification using TCGA data.利用TCGA数据的混合经典与量子计算用于增强胶质瘤肿瘤分类
Sci Rep. 2025 Jul 17;15(1):25935. doi: 10.1038/s41598-025-97067-3.
3
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.

本文引用的文献

1
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer.体细胞突变驱动肺癌中不同的影像学表型。
Cancer Res. 2017 Jul 15;77(14):3922-3930. doi: 10.1158/0008-5472.CAN-17-0122. Epub 2017 May 31.
2
Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.低级别胶质瘤的放射基因组学:在一项利用癌症基因组图谱数据的多机构研究中,通过算法评估的肿瘤形状与肿瘤基因组亚型及患者预后相关。
J Neurooncol. 2017 May;133(1):27-35. doi: 10.1007/s11060-017-2420-1. Epub 2017 May 3.
3
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
一种用于整合转录组学、蛋白质组学和放射组学数据以预测异柠檬酸脱氢酶(IDH)突变型胶质瘤患者复发情况的多模态策略。
Int J Cancer. 2025 Aug 1;157(3):573-587. doi: 10.1002/ijc.35441. Epub 2025 Apr 11.
4
Radiomics in glioma: emerging trends and challenges.神经胶质瘤中的放射组学:新趋势与挑战
Ann Clin Transl Neurol. 2025 Mar;12(3):460-477. doi: 10.1002/acn3.52306. Epub 2025 Feb 3.
5
From Images to Genes: Radiogenomics Based on Artificial Intelligence to Achieve Non-Invasive Precision Medicine in Cancer Patients.从图像到基因:基于人工智能的放射基因组学助力癌症患者实现无创精准医疗
Adv Sci (Weinh). 2025 Jan;12(2):e2408069. doi: 10.1002/advs.202408069. Epub 2024 Nov 13.
6
Artificial intelligence-based MRI radiomics and radiogenomics in glioma.基于人工智能的脑胶质瘤 MRI 影像组学和放射组学。
Cancer Imaging. 2024 Mar 14;24(1):36. doi: 10.1186/s40644-024-00682-y.
7
A novel deep learning model for glioma epilepsy associated with the identification of human cytomegalovirus infection injuries based on head MR.一种基于头部磁共振成像用于识别与人类巨细胞病毒感染损伤相关的胶质瘤癫痫的新型深度学习模型。
Front Microbiol. 2023 Nov 2;14:1291692. doi: 10.3389/fmicb.2023.1291692. eCollection 2023.
8
Current role of machine learning and radiogenomics in precision neuro-oncology.机器学习和放射基因组学在精准神经肿瘤学中的当前作用。
Explor Target Antitumor Ther. 2023;4(4):545-555. doi: 10.37349/etat.2023.00151. Epub 2023 Jul 19.
9
A transfer learning approach on MRI-based radiomics signature for overall survival prediction of low-grade and high-grade gliomas.基于 MRI 的放射组学特征的迁移学习方法用于预测低级别和高级别脑胶质瘤的总生存期。
Med Biol Eng Comput. 2023 Oct;61(10):2699-2712. doi: 10.1007/s11517-023-02875-2. Epub 2023 Jul 11.
10
Deep learning-assisted radiomics facilitates multimodal prognostication for personalized treatment strategies in low-grade glioma.深度学习辅助的放射组学有助于低级别胶质瘤的个体化治疗策略的多模态预后。
Sci Rep. 2023 Jun 11;13(1):9494. doi: 10.1038/s41598-023-36298-8.
用于预测1p19q共缺失弥漫性胶质瘤患者预后的多基因特征
Neuro Oncol. 2017 Jun 1;19(6):786-795. doi: 10.1093/neuonc/now285.
4
MRI features predict survival and molecular markers in diffuse lower-grade gliomas.磁共振成像特征可预测弥漫性低级别胶质瘤的生存率及分子标志物。
Neuro Oncol. 2017 Jun 1;19(6):862-870. doi: 10.1093/neuonc/now256.
5
Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.多参数 MRI 放射组学特征作为晚期鼻咽癌的新型预后因素。
Clin Cancer Res. 2017 Aug 1;23(15):4259-4269. doi: 10.1158/1078-0432.CCR-16-2910. Epub 2017 Mar 9.
6
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.计算医学成像(影像组学)在肿瘤学中的应用:承诺与挑战。
Ann Oncol. 2017 Jun 1;28(6):1191-1206. doi: 10.1093/annonc/mdx034.
7
Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response.复发性胶质母细胞瘤的大规模放射组学分析确定了一种用于分层抗血管生成治疗反应的影像预测指标。
Clin Cancer Res. 2016 Dec 1;22(23):5765-5771. doi: 10.1158/1078-0432.CCR-16-0702. Epub 2016 Oct 10.
8
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.基于微血管侵犯的新型预后列线图预测肝细胞癌R0切除术后患者的生存结局
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
9
Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.利用下一代成像技术解析肿瘤异质性:放射组学、放射基因组学和栖息地成像
Clin Radiol. 2017 Jan;72(1):3-10. doi: 10.1016/j.crad.2016.09.013. Epub 2016 Oct 11.
10
Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.乳腺癌异质性:磁共振成像纹理分析与生存结局。
Radiology. 2017 Mar;282(3):665-675. doi: 10.1148/radiol.2016160261. Epub 2016 Oct 4.